Valuation: ABL Diagnostics

Market Cap 4.31Cr 4.92Cr 3.97Cr 3.68Cr 6.98Cr 467.07Cr 7.1Cr 48Cr 19Cr 230.51Cr 18Cr 18Cr 796.74Cr P/E 2024
123x
P/E 2025 50x
Enterprise Value 4.4Cr 5.03Cr 4.05Cr 3.76Cr 7.13Cr 477.19Cr 7.25Cr 49Cr 19Cr 235.5Cr 19Cr 18Cr 813.99Cr EV / Sales 2024
70,98,474x
EV / Sales 2025 61,85,843x
Free-Float
2.52%
Yield 2024
2.03%
Yield 2025 3.67%
1 day-3.73%
1 week+3.20%
Current month-7.19%
1 month-7.19%
3 months-9.15%
6 months-31.38%
Current year-14.00%
1 week 2.54
Extreme 2.54
2.96
1 month 2.2
Extreme 2.2
2.96
Current year 2.12
Extreme 2.12
5
1 year 2.12
Extreme 2.12
5.75
3 years 2.12
Extreme 2.12
9.7
5 years 1.99
Extreme 1.9875
26
10 years 1.28
Extreme 1.275
26
Manager TitleAgeSince
Chief Executive Officer - -
Director TitleAgeSince
Chairman - -
Director/Board Member - -
Director/Board Member - -
Date Insider Type Main position Quantity % Market Cap.
02/06
Advanced Biological Laboratories SA
SellCompany -57,692 0.3580%
27/05
Advanced Biological Laboratories SA
SellCompany -51,900 0.3221%
17/03
Advanced Biological Laboratories SA
SellCompany 54,745 0.3397%
Change 5-day change 1-year change 3-year change Capi.($)
-3.73%+3.20%-52.22%-71.17% 4.92Cr
+0.22%+5.62%-28.32%-9.88% 17TCr
+0.93%+7.16%-4.38%-2.40% 11TCr
+1.99%+7.60%+0.65%+59.53% 5.81TCr
+0.27%-0.62%+54.16%+57.62% 5.27TCr
+0.49%+3.28%-9.63%-39.16% 4.29TCr
+0.61%+9.05% - - 3.61TCr
+1.64%+9.24%-11.30%-41.94% 2.79TCr
-0.44%-0.81%+60.77%-4.18% 2.53TCr
+0.99%+2.29%-7.68%-1.13% 2.08TCr
Average +0.32%+3.26%+0.23%-5.86% 5.37TCr
Weighted average by Cap. +0.83%+2.76%-3.29%+3.22%

Financials

2024 2025
Net sales 5.87 6.71 5.41 5.01 9.52 636.57 9.67 64.86 25.22 314.16 25.18 24.64 1.09T 7.97 9.1 7.34 6.8 12.92 863.91 13.13 88.03 34.23 426.36 34.17 33.43 1.47T
Net income 3L 3L 3L 2L 5L 3.09Cr 5L 31.51L 12.26L 1.53Cr 12.23L 11.97L 5.28Cr 10L 11.28L 9L 8L 16L 11Cr 16.26L 1.09Cr 42.4L 5.28Cr 42.33L 41.41L 18Cr
Net Debt 20.24L 23.13L 18.65L 17.29L 32.82L 22Cr 33.35L 2.24Cr 86.97L 11Cr 86.82L 84.94L 37Cr 9L 10.66L 9L 8L 15.12L 10Cr 15.37L 1.03Cr 40.08L 4.99Cr 40.01L 39.15L 17Cr
Logo ABL Diagnostics
ABL Diagnostics specializes in the development of software for collecting and processing medical databases, measuring the quality of care, diagnosing infectious diseases (AIDS, viral hepatitis and tuberculosis) by genotyping, and providing decision support for doctors and nurses, virology and microbiology laboratories, and researchers dealing with patients suffering from chronic and complex diseases. Export accounts for 69.7% of net sales.
Employees
22
Date Price Change Volume
07/26/07 2.580 -3.73% 1,084
06/26/06 €2.680 +0.75% 1,145
03/26/03 €2.660 +0.76% 5,087
02/26/02 €2.640 -5.04% 67,260
01/26/01 €2.780 0.00% 7,954

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ABLD Stock